A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2002
11/07/2002	DE10121252A1 Behandlung der Akne Treatment of acne
11/07/2002	DE10120505A1 Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen Use of stimulated peripheral blood mononuclear cells for the treatment of cancer
11/07/2002	CA2744115A1 Carbonic anhydrase activators for enhancing learning and memory
11/07/2002	CA2665516A1 Drug efflux pump inhibitor
11/07/2002	CA2450018A1 Crystal of 6-[4-(4-pyridylamino)phenyl]-4, 5-dihydro-3(2h)-pyridazinone hydrochloride trihydrate
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2446497A1 Crf receptor antagonists
11/07/2002	CA2446079A1 Modulators of elastase inhibitor secretion
11/07/2002	CA2446064A1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
11/07/2002	CA2446023A1 Cell adhesion and extracellular matrix proteins
11/07/2002	CA2445967A1 Compositions comprising lopinavir and methods for enhancing the bioavailability of pharmaceutical agents
11/07/2002	CA2445947A1 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002	CA2445871A1 Combinations of aldose reductase inhibitors and cyclooxygenase-2 inhibitors
11/07/2002	CA2445839A1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha
11/07/2002	CA2445819A1 Recombinant expression of hhbv reverse transcriptase (rt)
11/07/2002	CA2445811A1 Modified fvii in treatment of ards
11/07/2002	CA2445763A1 Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
11/07/2002	CA2445697A1 Drug efflux pump inhibitor
11/07/2002	CA2445593A1 Genetically modified yt cell line and use thereof
11/07/2002	CA2445581A1 Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoxaline
11/07/2002	CA2445568A1 Triazole-derived kinase inhibitors and uses thereof
11/07/2002	CA2445565A1 Compositions and methods of double-targeting virus infections and cancer cells
11/07/2002	CA2445552A1 Antidepressant (sssri) azaheterocyclymethyl derivatives of 7,8-dihydro-3h-t,9-dioxa-1,3-diazacyclopenta[a]naphthalene
11/07/2002	CA2445528A1 Treatment of psychotic disorders comprising co-therapy with anticonvulsant derivatives and atypical antipsychotics
11/07/2002	CA2445524A1 Stent-based delivery of statins to prevent restenosis
11/07/2002	CA2445376A1 Substance rkb-3564 having angiogenesis inhibitory action
11/07/2002	CA2445373A1 Use of phyllanthus constituents for treating or preventing infections caused by hepatitis b viruses
11/07/2002	CA2445357A1 Pyrazole derived kinase inhibitors
11/07/2002	CA2445343A1 Use of protein and essential amino acids to treat amenorrhea and related disorders
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2445330A1 Potassium channel opener
11/07/2002	CA2445314A1 Supplementary immunotherapeutics to be used after lung cancer removal
11/07/2002	CA2445266A1 Foot and mouth disease virus vaccine
11/07/2002	CA2445262A1 Method for treating tumors by the administration of tegafur, uracil, folinic acid, and cyclophosphamide
11/07/2002	CA2444911A1 Fusion molecules and methods for treatment of immune diseases
11/07/2002	CA2444882A1 Inhibitors of gsk-3 and crystal structures of gsk-3.beta. protein and protein complexes
11/07/2002	CA2444727A1 Agents for preventing postoperative recurrence of premenopausal breast cancer
11/07/2002	CA2444499A1 Triazole compounds useful in treating diseases associated with unwanted cytokine activity
11/07/2002	CA2444436A1 Dual inhibitors of pde 7 and pde 4
11/07/2002	CA2444334A1 Pharmaceutical combinations based on pyridoindolone derivatives and anticancer agents
11/07/2002	CA2443835A1 Fused heterocyclic inhibitors of phosphodiesterase (pde) 7
11/07/2002	CA2440775A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	CA2429001A1 Cysteine protease inhibitors
11/07/2002	CA2408369A1 Substituted indoles as parp inhibitors
11/06/2002	EP1255112A2 Treatment of T-cell mediated diseases
11/06/2002	EP1254956A2 Novel osteoinductive compositions
11/06/2002	EP1254953A1 Maturation-promoting agent for immature dendritic cells
11/06/2002	EP1254905A1 4-(2-Pyridyl)piperazines having 5HT7 receptor agonist activity
11/06/2002	EP1254902A1 Agents correcting gene expression regulatory error
11/06/2002	EP1254899A2 Piperazine derivatives and their use as anti-inflammatory agents
11/06/2002	EP1254898A1 Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
11/06/2002	EP1254897A1 Tricyclic compounds
11/06/2002	EP1254890A1 Derivatives of 3,3-diphenylpropylamines
11/06/2002	EP1254662A2 Methods and kits for treating depression or preventing deterioration of cognitive function
11/06/2002	EP1254661A1 Method for preventing dyskinesias with selective NMDA-Antagonists
11/06/2002	EP1254660A2 Methods, kits and compositions for using pyrrole derivatives against anxiety
11/06/2002	EP1254658A1 Remedies
11/06/2002	EP1254270A1 Methods and materials relating to cub domain polypeptides and polynucleotides
11/06/2002	EP1254265A1 Methods and materials relating to metallocarboxypeptidase-like polypeptides and polynucleotides
11/06/2002	EP1254255A1 Trefoil domain-containing polynucleotides, polypeptides, and antibodies
11/06/2002	EP1254251A2 Neurosteroids as markers for alzheimer's disease
11/06/2002	EP1254242A1 17 human secreted proteins
11/06/2002	EP1254241A2 Phosphatases
11/06/2002	EP1254240A2 Proteins producing an altered immunogenic response and methods of making and using the same
11/06/2002	EP1254236A2 Drug metabolizing enzymes
11/06/2002	EP1254235A2 Drug metabolizing enzymes
11/06/2002	EP1254222A1 Human gaba receptor proteins and polynucleotides encoding the same
11/06/2002	EP1254214A2 Human protein kinases and protein kinase-like enzymes
11/06/2002	EP1254212A2 Methods of preparing and using a viral vector library
11/06/2002	EP1254209A2 Bioavailable composition of natural and synthetic hca
11/06/2002	EP1254180A1 Canine allergy therapeutic recombinant chimeric anti-ige monoclonal antibody
11/06/2002	EP1254176A2 Trade molecules and uses related thereto
11/06/2002	EP1254174A2 Human cyr61
11/06/2002	EP1254169A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or t cell subset activity by modulation of xbp-1 activity
11/06/2002	EP1254145A1 N,o-amidomalonate platinum complexes
11/06/2002	EP1254139A1 4-heteroaryl-1,4-diazabicyclo 3.2.2]nonane, preparation and therapeutic use thereof
11/06/2002	EP1254138A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase
11/06/2002	EP1254137A1 PYRIDO 2,3-d]PYRIMIDINE-2,7-DIAMINE KINASE INHIBITORS
11/06/2002	EP1254134A2 1,3-dihydro-2h-indol-2-one derivatives,and their use as ligands for v1b or v1b and v1a arginine-vasopressin-receptors
11/06/2002	EP1254133A2 Indol-3-yl derivatives
11/06/2002	EP1254124A1 Dipeptide nitrile cathpsin k inhibitors
11/06/2002	EP1254123A1 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
11/06/2002	EP1254121A1 Preparation of sulfonamides
11/06/2002	EP1254120A1 Use of pyrimidine endothelin antagonists in companion animals
11/06/2002	EP1254119A1 Pyrimidine derivatives as selective inhibitors of cox-2
11/06/2002	EP1254116A1 Alpha v integrin receptor antagonists
11/06/2002	EP1254114A2 Melanocortin receptor agonists and antagonists
11/06/2002	EP1254113A1 N-substituted 2-cyanopyroles and -pyrrolines which are inhibitors of the enzyme dpp-iv
11/06/2002	EP1254108A1 Gamma-secretase inhibitors
11/06/2002	EP1254106A1 Calcilytic compounds
11/06/2002	EP1254102A1 Alkynylsubstituted propionic acid derivatives and their use against diabetes and obesity
11/06/2002	EP1253945A2 Ace inhibitor-vasopressin antagonist combinations
11/06/2002	EP1253937A2 Methods of therapy with thrombin derived peptides
11/06/2002	EP1253931A2 Utilization of protein kinase inhibitor alpha
11/06/2002	EP1253925A1 Tetrahydropyrimidone inhibitors of fatty acid binding protein and method
11/06/2002	EP1253919A1 Method and compositions for treating an inflammatory disease
11/06/2002	EP1253915A1 Method for treating stress with a precursor of serotonin
11/06/2002	EP1253906A1 Cosmetic preparations containing waltheria indica extracts
11/06/2002	EP1253904A2 Extracts from residues left in the production of wine
11/06/2002	EP1157024B1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors

1 ... 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 ... 1564